Ironwood Pharmaceuticals
IRWD
138 hedge funds and large institutions have $1.62B invested in Ironwood Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 37 reducing their positions, and 8 closing their positions.
188% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 8
62% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 37
29% more call options, than puts
Call options by funds: $7.02M | Put options by funds: $5.44M
23% more capital invested
Capital invested by funds: $1.32B → $1.62B (+$300M)
11% more funds holding
Funds holding: 124 → 138 (+14)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.6M |
| 2 |
Millennium Management
New York
|
+$60.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$40.5M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VM
VHCP Management
New York
|
-$12.1M |
| 2 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
-$9.07M |
| 3 |
TG
TCW Group
Los Angeles,
California
|
-$8.03M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.94M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.41M |
IRWD Hedge Fund Activity: Q1 2014 in Review
138 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q1 2014, worth a combined $1.62B — up 23% from $1.32B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new IRWD positions and 8 closed out — a net gain of 15 holders — while 60 added to existing stakes and 37 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $65.6M. The largest seller was VHCP Management, cutting an estimated $12.1M.
- 138 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q1 2014, up from 124 in Q4 2013.
- Funds reported $1.62B of Ironwood Pharmaceuticals stock for Q1 2014, up 23% quarter-over-quarter.
- 23 funds opened new Ironwood Pharmaceuticals positions in Q1 2014 and 8 closed out, a net change of +15 holders.
- The largest Ironwood Pharmaceuticals buyer in Q1 2014 was Fidelity Investments, an estimated $65.6M added.
- The largest Ironwood Pharmaceuticals seller in Q1 2014 was VHCP Management, an estimated $12.1M sold.
Based on aggregated 13F filings for Q1 2014.